As expected, a large number of immune cell infiltrates was observed in tumor tissues because of the OMV-PD1 induced PD-L1 blocked on the surface of tumor cells, which suggests that genetically engineered OMV-PD1 has reversed the immunosuppressive TME in CRC besides specific target. This evidence concerns the gene PDCD1 and colorectal carcinoma.